Department of Orthopedic Surgery, Third Hospital of Shijiazhuang, ChangAn District, , Shijiazhuang, 050011, HeBei, China.
Department of Orthopedic Surgery and Sports Medicine Center, The First Affiliated Hospital of Jinan University, Road West No. 613, Huang-Pu, Guangzhou, 510632, GuangDong, China.
J Bone Miner Metab. 2021 Jul;39(4):534-546. doi: 10.1007/s00774-020-01199-7. Epub 2021 Feb 10.
To investigate the role of LncRNA PVT1 (plasmacytoma variant translocation 1) in hyperglycemia-triggered cartilage damage using the diabetic osteoarthritis (OA) mice model.
Streptozotocin (STZ) was used to induce mouse diabetes. Knee OA model was induced through transection of anterior cruciate ligament (ACLT). Severity of arthritis was assessed histologically by Safranin O-Fast Green Staining using Mankin Scores. LncRNA PVT1 and miR-146a were detected by real-time polymerase chain reaction (PCR) in cartilage tissue. Moreover, the interaction among PVT1, miR-146a, and SMAD4 was examined by luciferase reporter assays. Mice were injected intra-articularly with ad-siRNA-PVT1 and ad-siRNA scramble control. Articular concentrations of TNF-α, IL-1, IL-6 and TGF-β1 were determined using enzyme-linked immunosorbent assay. Levels of type II Collagen (COL2A1), TGF-β1, p-SMAD2, SMAD2, p-SMAD3, SMAD3, SMAD4 and nuclear SMAD4 were detected by western blot analysis.
PVT1 expression was significantly increased, whereas miR-146a was markedly decreased in diabetic OA mice than in non-diabetic OA and control. Increased PVT1 expression in diabetic OA mice was significantly associated with Mankin score and reduced miR-146a as well as Collagen alpha-1(II) (COL2A1) expressions. In vivo, intra-articular injection of ad-siRNA-PVT1 efficiently increased miR-146a and COL2A1 expressions, alleviated joint inflammation, decreased the expression of pro-inflammatory mediators, and suppressed TGF-β/SMAD4 pathway in diabetic OA mice.
Our results demonstrate LncRNA PVT1 is involved in cartilage degradation in diabetic OA and correlated with disease severity. Efficiency of ad-siRNA-PVT1 in controlling joint inflammation in diabetic OA mice is associated with the suppression of the expression of miR-146a, pro-inflammatory cytokines and activation of TGF-β/SMAD4 pathway.
使用糖尿病性骨关节炎(OA)小鼠模型研究长链非编码 RNA PVT1(浆细胞瘤变异易位 1)在高血糖引发的软骨损伤中的作用。
链脲佐菌素(STZ)用于诱导小鼠糖尿病。通过前交叉韧带(ACL)横断术诱导膝骨关节炎(OA)模型。通过番红 O-快绿染色用 Mankin 评分法评估关节炎的严重程度。通过实时聚合酶链反应(PCR)检测软骨组织中的长链非编码 RNA PVT1 和 miR-146a。此外,通过荧光素酶报告基因检测 PVT1、miR-146a 和 SMAD4 之间的相互作用。通过关节内注射 ad-siRNA-PVT1 和 ad-siRNA 对照来检测小鼠。使用酶联免疫吸附测定法测定关节内 TNF-α、IL-1、IL-6 和 TGF-β1 的浓度。通过 Western blot 分析检测 II 型胶原(COL2A1)、TGF-β1、p-SMAD2、SMAD2、p-SMAD3、SMAD3、SMAD4 和核 SMAD4 的水平。
与非糖尿病性 OA 和对照组相比,糖尿病性 OA 小鼠的 PVT1 表达显著增加,而 miR-146a 表达显著降低。糖尿病性 OA 小鼠中 PVT1 表达的增加与 Mankin 评分以及 miR-146a 和 Collagen alpha-1(II)(COL2A1)表达的降低显著相关。在体内,关节内注射 ad-siRNA-PVT1 可有效增加 miR-146a 和 COL2A1 的表达,减轻关节炎症,降低促炎介质的表达,并抑制糖尿病性 OA 小鼠中的 TGF-β/SMAD4 途径。
我们的结果表明,长链非编码 RNA PVT1 参与了糖尿病性 OA 中的软骨降解,并且与疾病的严重程度相关。ad-siRNA-PVT1 控制糖尿病性 OA 小鼠关节炎症的效率与抑制 miR-146a、促炎细胞因子的表达和 TGF-β/SMAD4 途径的激活有关。